Neoadjuvant (preoperative) Systemic therapy for breast cancer
VF Semiglazov · Geburtshilfe und Frauenheilkunde · 2011 · Heft 11
Bibliografische Angaben
Zusammenfassung
Part I. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin study Aim : To describe surgical outcomes in patients with HER2-positive locally advanced (LABC) or inflammatory breast cancer (IBC) participating in the NeOAdjuvant Herceptin (NOAH) study (ISRCTN86043495). Patients and Methods : A total of 235 patients with HER2-positive disease were randomized to neoadjuvant trastuzumab. plus chemotherapy (doxorubicin plus paclitaxel, followed by paclitaxel, followed by cyclophosphamide, methotrexate and fluorour…